Error in Conclusions

In the Original Investigation titled “Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial,” published online March 16, 2026, there was an error in the Conclusions section. The first sentence should have read, “In this trial, pregnant adults with OUD who were randomized to receive extended-release buprenorphine had higher rates of illicit opioid abstinence during pregnancy than those randomized to receive sublingual buprenorphine.” This article has been corrected.

from JAMA Internal Medicine Online First https://ift.tt/76MOoGY